Safety, Tolerability, and Sustained Weight Loss of Endoscopic Sleeve Gastroplasty With Diet Modification and Exercise

Inclusion Criteria

• •BMI greater than or equal to 40 kg/m2, greater than or equal to to 30 kg/m2 with 1 more obesity related co-morbidity, or or greater than or equal to 35 kg/m2 without co-morbidity
• •Co-morbidities include:
• •1. Sleep apnea (STOP-BANG questionnaire and polysomnography)
• •2. BP \>130/80 or on hypertension meds.
• •3. A1c \> or = to 5.7, fasting \>100 OR RANDOM \>126, exclude 6.5 and above
• •4. Waist circumference \>102, or 40 inches if male or \>80 cm 35 inches if female
• •5. Metabolic syndrome (3 criteria, blood pressure, waist circumference, triglycerides \> 150 or HDL \< 50/40)
• •* Failure to respond to non-invasive weight loss management for at least 6 months.
• •* Valid health insurance to cover the cost of procedure and standard of care pre-and post-procedure management/workup.